Roche Launches New Program To Ease Tamiflu Access

Roche has launched a new program to ease Tamiflu access to developing economies. The Tamiflu Reserves Program is designed as a pandemic insurance policy for the world’s developing economies.

Roche has initiated the Tamiflu Reserves Program (TRP) for developing economies. The program would serve to ensure that Tamiflu (oseltamivir) is available to governments and patients in developing nations for use, as WHO has declared influenza pandemic.

Under the TRP program, Roche will produce and store Tamiflu pandemic stockpiles for specified developing countries, at a significantly reduced price with the cost spread over a number of years. Roche will then ship the stockpile to the governments of countries concerned when an influenza pandemic has been announced, or in the event of a public health emergency.

The countries can exercise their option to purchase the product at any time, said the company.